Trial Profile
Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Ascorbic acid (Primary) ; Liraglutide (Primary)
- Indications Diabetic complications; Type 1 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 13 Feb 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 31 Aug 2018 Biomarkers information updated
- 01 Jul 2014 New trial record